The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer.

Br J Cancer · 2003 · PMC2376344 · PMID 12618879

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A difference in disease-specific survival at 6 years, 88% in nonusers vs 78% in tamoxifen users, did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.